Target intelligence / Profile preview

MicroRNA 4263 (MIR4263)

Target
MIR4263
Molecular classification
Other (microRNA, non-coding RNA)
01

Overview

MicroRNA 4263 (MIR4263) is a short, non-coding RNA molecule that belongs to the microRNA (miRNA) family, which regulates gene expression after transcription by affecting mRNA stability and translation efficiency[1][3]. Like other mammalian miRNAs, MIR4263 is transcribed by RNA polymerase II, processed by Drosha and Dicer ribonucleases, and incorporated into the RNA-induced silencing complex (RISC) to mediate gene silencing by binding mostly to the 3' untranslated regions of target mRNAs[1][2][3]. MIR4263 has been associated in the literature with motion sickness, but detailed functional or drug interaction data remain lacking[1]. There are no known drugs that specifically target MIR4263, and its utility as a biomarker or direct therapeutic target has not been established.

Other names
hsa-mir-4263MIR4263
02

Biological functions

Post-transcriptional regulation of gene expressionmRNA destabilization and translational inhibitionPotential cell-cell communication role
03

Disease associations

Motion sickness (reported association)Other (microRNAs are potentially involved in numerous diseases, but specific disease associations for microRNA 4263 are limited)
04

Safety considerations

microRNAs may have off-target effects and present delivery challenges as therapeutics or biomarkers, but no specific safety concerns noted for MIR4263

Beyond the preview

Go deeper on MicroRNA 4263 (MIR4263).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4263 (MIR4263).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call